by University of Cincinnati Romo-Nava received a patent for the noninvasive spinal cord stimulation device in 2020. Credit: Colleen Kelley/UC Marketing + Brand. A pilot clinical trial led by University of Cincinnati researchers at the Lindner Center of HOPE found electrical stimulation of the spinal cord is feasible, well-tolerated and shows therapeutic potential to treat depression....
by Wiley Credit: CC0 Public Domain Results from a Phase II clinical trial indicate that psilocybin, a hallucinogenic chemical found in certain mushrooms of the genus Psilocybe, may benefit individuals with cancer and major depression. Trial participants treated with psilocybin not only experienced a lessening of depressive symptoms but also spoke highly of the therapy when...
by UC Davis Credit: CC0 Public Domain A non-hallucinogenic version of the psychedelic drug ibogaine, with potential for treating addiction, depression and other psychiatric disorders, has been developed by researchers at the University of California, Davis. A paper describing the work is published Dec. 9 in Nature. “Psychedelics are some of the most powerful drugs we...
by University of British Columbia Credit: CC0 Public Domain A special kind of genetic test that helps determine the best antidepressant for patients with moderate-to-severe depression could generate substantive health system savings and greatly improve patient outcomes, according to new research from the University of British Columbia. The study, published today in the Canadian Medical Association...
Precise observation using ultra-high magnetic field 7T MRIPeer-Reviewed Publication NATIONAL RESEARCH COUNCIL OF SCIENCE & TECHNOLOGY (A) BRAIN REGIONS WHERE SPECTRA WERE MEASURED (YELLOW BOX) (B) 1H MR SPECTRUM IN THE HIPPOCAMPUS: HIPPOCAMPAL TAURINE SIGNAL SHOWN AT 3.4 PPM (ARROW). BLACK LINE: ACTUAL MEASURED SPECTRUM. RED LINE: LCMODEL FITTING SPECTRUM. ABBREVIATION: TAU, TAURINE; CHO, CHOLINE;...
by American Heart Association Credit: Unsplash/CC0 Public Domain The heart and mind are strongly connected, with depression, anxiety and chronic stress all increasing the risk for heart and brain health complications, according to two preliminary studies to be presented at the American Heart Association’s Scientific Sessions 2023, held Nov. 11–13, in Philadelphia. Mental health conditions, including depression,...
Eve Bender October 30, 2023 TOPLINE: Ketamine was no more effective than placebo in reducing depressive symptoms in surgical patients with major depressive disorder (MDD), results of a new study, which contradict prior research, suggest. Although symptoms improved in both study groups, investigators say participants’ expectations of an improvement from ketamine may be driving that result. METHODOLOGY: TAKEAWAY:...
Sharon Worcester, MA August 29, 2023 Depression and anxiety were not associated with outcomes for most cancer types, including breast cancer, prostate cancer, and alcohol-related cancer, according to findings from a large, individual participant data meta-analysis. An exception was for lung and smoking-related cancers, but key covariates appeared to explain the relationship between depression, anxiety, and these...
by Alan Mozes Highly processed packaged foods and drinks may be quick, cheap and tasty, but new research suggests they’re also likely to up your risk for depression. Among big consumers of ultra-processed foods, depression risk may rise by as much as 50%, the new study found, particularly when those foods are artificially sweetened. “Given...
(Adobe Stock)Tuesday, 24 October 2023 04:38 PM EDT The party drug ketamine has gotten a lot of notice for its potential to help people with severe and persistent depression who haven’t responded to other treatments. But a new study has discovered the drug’s effect may be in the heads of patients who take it. Researchers...
